Showing results (41-50 of 706) with videos related to
Sort By:
Pageof 71
Trends in Molecular Medicine|May 1, 2024
Novel bladder-sparing approaches in patients with muscle-invasive bladder cancerReuben Ben-David, Matthew D Galsky, John P SfakianosCA: a Cancer Journal for Clinicians|August 9, 2020
Treatment of muscle-invasive and advanced bladder cancer in 2020Vaibhav G Patel, William K Oh, Matthew D GalskyEuropean Journal of Cancer (Oxford, England : 1990)|April 27, 2021
The effect of adding immune checkpoint inhibitors on the risk of pneumonitis for solid tumours: a meta-analysis of phase III randomised controlled trialsYu Fujiwara, Nobuyuki Horita, Ho Namkoong, et al.European Urology Open Science|August 2, 2021
Neoadjuvant Immunotherapy: The Next Gold Standard Before Radical Surgery for Urothelial CancerDaniele Raggi, Marco Moschini, Andrea NecchiUrologic Oncology|March 22, 2016
Systemic adjuvant therapy for renal cell carcinoma: Any hope for future clinical trials?Reza Mehrazin, Che-Kai Tsao, John Sfakianos, et al.Urologic Oncology|September 20, 2020
Second line salvage systemic therapy for advanced penile cancerJad Chahoud, Monica Tamil, Andrea NecchiTranslational Andrology and Urology|January 23, 2018
Current markers and their value in the era of immuno-oncologyFriedrich-Carl von Rundstedt, Andrea NecchiCancer Treatment Reviews|April 13, 2015
The landscape of precision cancer medicine clinical trials in the United StatesNitin Roper, Kristian D Stensland, Ryan Hendricks, et al.Future Oncology (London, England)|June 22, 2018
Nivolumab and its use in the second-line treatment of metastatic urothelial cancerDaniele Raggi, Andrea Necchi, Patrizia GiannatempoCurrent Opinion in Urology|January 9, 2020
Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledgeMarco Bandini, Filippo Pederzoli, Andrea NecchiPageof 71